Evidence map›Paper›PMID 28377607›Full record

ArticleScientific reports2017

Loss of p27

Stefania Berton, Martina Cusan, Ilenia Segatto, Francesca Citron, Sara D'Andrea, Sara Benevol, Michele Avanzo, Alessandra Dall'Acqua, Monica Schiappacassi, Robert G Bristow and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. WIP1 dephosphorylation of p27Cell cycle (Georgetown, Tex.) · 2020
    Article
  13. Review
  14. MicroRNA-186 targets SKP2 to induce p27The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2019
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Stefania BertonDivision of Molecular Oncology, CRO of Aviano, National Cancer Institute, Aviano, 33081, Italy.
Martina CusanDivision of Molecular Oncology, CRO of Aviano, National Cancer Institute, Aviano, 33081, Italy.
Ilenia SegattoDivision of Molecular Oncology, CRO of Aviano, National Cancer Institute, Aviano, 33081, Italy.
Francesca CitronDivision of Molecular Oncology, CRO of Aviano, National Cancer Institute, Aviano, 33081, Italy.
Sara D'AndreaDivision of Molecular Oncology, CRO of Aviano, National Cancer Institute, Aviano, 33081, Italy.
Sara BenevolDivision of Molecular Oncology, CRO of Aviano, National Cancer Institute, Aviano, 33081, Italy.
Michele AvanzoDivision of Medical Physics, CRO of Aviano, National Cancer Institute, Aviano, 33081, Italy.ORCID http://orcid.org/0000-0003-1711-4242
Alessandra Dall'AcquaDivision of Molecular Oncology, CRO of Aviano, National Cancer Institute, Aviano, 33081, Italy.
Monica SchiappacassiDivision of Molecular Oncology, CRO of Aviano, National Cancer Institute, Aviano, 33081, Italy.
Robert G BristowPrincess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Barbara BellettiDivision of Molecular Oncology, CRO of Aviano, National Cancer Institute, Aviano, 33081, Italy. bbelletti@cro.it.ORCID http://orcid.org/0000-0003-2249-0285
Gustavo BaldassarreDivision of Molecular Oncology, CRO of Aviano, National Cancer Institute, Aviano, 33081, Italy. gbaldassarre@cro.it.ORCID http://orcid.org/0000-0002-9750-8825
Centro di Riferimento Oncologico · ITNational Cancer Institute · UAUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genomic instability represents a typical feature of aggressive cancers. Normal cells have evolved intricate responses to preserve genomic integrity in response to stress, such as DNA damage induced by γ-irradiation. Cyclin-dependent kinases (CDKs) take crucial part to these safeguard mechanisms, but involvement of CDK-inhibitors, such as p27

Indexed as

Genomic InstabilityAnimalsBreast NeoplasmsCell Line, TumorCell SurvivalCyclin-Dependent Kinase Inhibitor p27DNA DamageFemaleGene ExpressionGene Knockout TechniquesHumansMCF-7 CellsMiceMicronuclei, Chromosome-DefectiveMitosisMutationCyclin-Dependent Kinase Inhibitor p27

Identifiers

PMID28377607
PMCPMC5429596
OpenAlexW2600759447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.